A role for angiogenesis in rheumatoid arthritis

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 5, 1999, Pages 573-581

  Stupack, D C ^a   Storgard, C M ^a   Cheresh, D A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Arthritis; Endothelium; Integrin

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; VITRONECTIN RECEPTOR;

ANIMAL; IMMUNOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ARTHRITIS, RHEUMATOID; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VITRONECTIN; SYNOVIAL MEMBRANE;

EID: 0033125439     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000500011     Document Type: Article

References (61)

1. Pincus T (1995). The underestimated long term medical and economic consequences of rheumatoid arthritis. Drugs, 50 (Suppl 1): 1-14.
2. McCabe CJ (1997). Health economics in rheumatology. Baillieres Clinical Rheumatology, 11: 145-156.
3. Zvaifler NJ & Firestein GS (1994). Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis. Arthritis and Rheumatism, 37: 783-789.
4. Shiozawa S & Tokuhisa T (1992). Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis. Seminars in Arthritis and Rheumatology, 21: 267-273.
5. Kimball ES & Gross JL (1991). Angiogenesis in pannus formation. Agents and Actions, 34: 329-331.
6. Colville-Nash PR & Scott DL (1992). Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Annals of the Rheumatic Diseases, 51:919-925.
7. Koch AE (1998). Angiogenesis: implications for rheumatoid arthritis. Arthritis and Rheumatism, 41: 951-962.
8. Matsubara T & Ziff M (1987). Inhibition of endothelial cell proliferation by gold compounds. Journal of Clinical Investigation, 79: 1440-1446.
9. Madhok R, Wijelath E, Smith J, Watson J, Sturrock RD & Capell HA (1991). Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization? Journal of Rheumatology, 18: 199-202.
10. Potvin F, Petitclerc E, Marceau F & Poubelle PE (1997). Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells. Journal of Immunology, 158: 1872-1879.
11. Hirata S, Matsubara T, Saura R, Tateishi H & Hirohata K (1989). Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low dose methotrexate. Arthritis and Rheumatism, 32: 1065-1073.
12. Matsubara T, Saura R, Hirohata K & Ziff M (1989). Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. Journal of Clinical Investigation, 83: 158-167.
13. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M & DuBois RN (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716.
14. Peacock DJ, Banquerigo ML & Brahn E (1995). A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cellular Immunology, 160: 178-184.
15. Oliver SJ, Banquerigo ML & Brahn E (1994). Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM1470, and a microtubule stabilizer, Taxol. Cellular immunology, 157: 291-299.
16. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1: 27-31.
17. Muller-Ladner U, Kriegsmann J, Gay RE & Gay S (1995). Oncogenes in rheumatoid arthritis. Rheumatic Diseases Clinics of North America, 21: 675-690.
18. Walsh DA, Wade M, Mapp PI & Blake DR (1998). Focally regulated endothelial proliferation and cell death in human synovium. American Journal of Pathology, 152: 691-702.
19. Varani J, Mulligan MS & Ward PA (1994). The vascular endothelium and acute inflammation. In: Klippel JH & Dieppe PA (Editors), Rheumatology. Mosby, St Louis.
20. Gualandris A, Rusnati M, Belleri M, Nelli EE, Bastaki M, Molinari-Tosatti MP, Bonardi F, Parolini S, Albini A, Morbidelli L, Ziche M, Corallini A, Possati L, Vacca A, Ribatti D & Presta M (1996). Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth and Differentiation, 7: 147-160.
21. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A & Marme D (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87: 3336-3343.
22. Eguchi K, Migita K, Nakashima M, Ida H, Terada K, Sakai M, Kawakami A, Aoyagi T, Ishimaru T & Nagataki S (1992). Fibroblast growth factors released by wounded endothelial cells stimulate proliferation of synovial cells. Rheumatology, 19: 1925-1932.
23. Mignatti P & Rifkin DB (1996). Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzymes and Proteins, 49: 117-137.
24. Ziats NP & Anderson JM (1993). Human vascular endothelial cell attachment and growth inhibition by type V collagen. Journal of Vascular Surgery, 17: 710-718.
25. Boudreau N, Andrews C, Srebrow A, Ravanpay A & Cheresh DA (1997). Regulation of the angiogenic phenotype by Hox D3. Journal of Cell Biology, 139: 257-264.
26. Meredith Jr JE, Fazeli B & Schwartz MA (1993). The extracellular matrix as a cell survival factor. Molecular Biology of the Cell. 4: 953-961.
27. Cornelius LA, Nehring LC, Roby JD, Parks WC & Welgus HG (1995). Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. Journal of Investigative Dermatology, 105: 170-176.
28. Dvorak HF, Brown LF, Detmar M(White vertical rectangle)& Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology, 146: 1029-1039.
29. Reininger AJ, Heinzmann U, Reininger CB, Friedrich P & Wurzinger LJ (1994). Flow mediated fibrin thrombus formation in an endothelium-lined model of arterial branching. Thrombosis Research, 74: 629-641.
30. Postigo AA, Garcia-Vicuna R, Laffon A & Sanchez-Madrid F (1993). The role of adhesion molecules in the pathogenesis of rheumatoid arthritis. Autoimmunity, 16: 69-76.
31. Busso N, Peclat V, Van Ness K, Kolodziesczyk E, Degen J, Bugge T & So A (1998). Exacerbation of antigen-induced arthritis in urokinase-deficient mice. Journal of Clinical Investigation, 102: 41-50.
32. Leavesley DI, Schwartz MA, Rosenfeld M & Cheresh DA (1990). Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. Journal of Cell Biology, 121: 163-170.
33. Lampugnani MG, Giorgi M, Gaboli M, Dejana E & Marchisio PC (1990), Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Laboratory Investigation, 63: 521-531.
34. Bull DA, Seftor EA, Hendrix MJ, Larson DF, Hunter GC & Putnam CW (1993). Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. Journal of Surgical Research, 55: 473-479.
35. Saiki I, Murata J, Makabe T, Nishi N, Tokura S & Azuma I (1990). Inhibition of tumor angiogenesis by a synthetic cell-adhesive polypeptide containing the ArgGly-Asp (RGD) sequence of fibronectin, poly(RGD). Japanese Journal of Cancer Research, 81: 668-675.
36. Aplin AE, Howe A, Alahari SK & Juliano RL (1998). Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules and selectins. Pharmacological Reviews, 50: 197-263.
37. Shimizu Y & Shaw S (1991). Lymphocyte interactions with extracellular matrix. FASEB Journal, 5: 2292-2299.
38. Gillis S, Furie BC & Furie B (1997). Interactions of neutrophils and coagulation proteins. Seminars in Hematology, 34: 336-342.
39. Simms H & D'Amica R (1994). Matrix protein regulation of PMN oxidative metabolism during ischemia. American Journal of Physiology, 266: C637-C647.
40. Eliceiri BP, Strömblad S, Klemke R & Cheresh DA (1998). Integrin requirement for sustained MAP kinase activity during angiogenesis. Journal of Cell Biology, 140: 1255-1263.
41. Short SM, Talbott GA & Juliano RL (1998). Integrin-mediated signaling events in human endothelial cells. Molecular Biology of the Cell, 9: 1969-1980.
42. Brooks PC, Clark RA & Cheresh DA (1994). Requirement of vascular integrin αvβ3 for angiogenesis. Science, 264: 569-571.
43. Varner JA, Brooks PC & Cheresh DA (1995). The integrin αvβ3: Angiogenesis and apoptosis. Cell Adhesion and Communication, 3: 367-374.
44. Brooks PC, Stromblad S, Sanders LC, von Schalscha T, Aimes RT, Stetler-Stevenson WG, Quigley JP & Cheresh DA (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell, 85: 1-20.
45. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G & Cheresh DA (1994). Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164.
46. Strömblad S, Becker JC, Yebra M, Brooks PC & Cheresh DA (1996). Suppression of p53 and p21WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis in vivo. Journal of Clinical Investigation, 98: 426-433.
47. Scatena M, Almeida ML, Fausto N, Nicosia RE & Giachelli CM (1998). NF-κB mediates αvβ3 integrin-induced endothelial cell survival. Journal of Cell Biology, 141: 1083-1093.
48. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA & Cheresh DA (1995). Definition of two angiogenic pathways by distinct αv integrins. Science, 270: 1500-1502.
49. Brooks PC, Strömblad S, Klemke R, Visscher D, Sarkar FH & Cheresh DA (1995). Anti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. Journal of Clinical Investigation, 96: 1815-1822.
50. Johnson BA, Haines GK, Harlow LA & Kock AE (1993). Adhesion molecule expression in human synovial tissue. Arthritis and Rheumatism, 36: 137-146.
51. Nikkari L, Haapasalmi K, Aho H, Torvinen A, Sheppard D, Larjava H & Heino J (1995). Localization of the av subfamily of integrins and their putative ligands in synovial lining cell layer. Journal of Rheumatology, 22: 16-23.
52. Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI & Cheresh DA (1999). Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. Journal of Clinical Investigation, 103: 1-8.
53. Wahl SM, Allen JB, Hines KL, Imamichi T, Wahl AM, Furcht LT & McCarthy JB (1994). Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. Journal of Clinical Investigation, 94: 655-662.
54. Hershkoviz R, Greenspoon N, Mekori YA, Hadari R, Alon R, Kapustina G & Lider O (1994). Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp. Clinical and Experimental Immunology, 95: 270-276.
55. Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kassler H, Timpl R & Engel J 11994). Selective recognition of cyclic RGD peptides of NMR defined conformation by αllββ3, αvβ3, and α5β1 integrins. Journal of Biological Chemistry, 2692: 20233-20238.
56. Brooks PC, Silletti S, von Schalscha TL, Friedlander M & Cheresh DA (1998). Disruption of angiogenesis by PEX, a non-catalytic metalloproteinase fragment with integrin binding activity. Cell, 92: 391-400.
57. Paleolog E (1997). Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNFalpha antibody in rheumatoid arthritis. Molecular Pathology, 50: 225-233.
58. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R & Sorg C (1994). Macrophages and angiogenesis. Journal of Leukocyte Biology, 55: 410-422.
59. Jackson JR, Minton JA, Ho ML, Wei N & Winkler JD (1997). Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1 beta. Journal of Rheumatology, 24: 1253-1259.
60. Ruegg C, Yilmaz A, Bieler G, Bamat J, Chaubert P & Lejeune FJ (1998). Evidence for the involvement of endothelial cell integrin αvβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nature Medicine, 4: 408-414.
61. Koch AE, Halloran MM, Hosaka S, Shah MR, Haskell CJ, Baker SK, Panos RJ, Haines GK, Bennett GL, Pope RM & Ferrara N (1996). Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis. Arthritis and Rheumatism, 39: 1566-1575.